MarketAngus Dalgleish
Company Profile

Angus Dalgleish

Angus George Dalgleish is a professor of oncology at St George's, University of London, best known for his contributions to HIV/AIDS research. Dalgleish stood in 2015 for Parliament as a UKIP candidate.

Education
Angus George Dalgleish was born in May 1950 in Harrow, London. Initially educated at the Harrow County School for Boys, Dalgleish received a Bachelor of Medicine, Bachelor of Surgery degree from University College London with an intercalated bachelor's degree in Anatomy. ==Career as medical researcher==
Career as medical researcher
After various positions in the United Kingdom, Dalgleish joined the Royal Flying Doctor Service in Mount Isa, Queensland, then progressed through positions at various hospitals in Brisbane, Australia, before moving to the Ludwig Institute for Cancer Research in Sydney. In 1986, he was appointed to a consulting position at Northwick Park Hospital, in 1991 he was made Foundation Professor of Oncology at St George's, University of London, In 1997, he founded Onyvax Ltd., a privately funded biotechnology company developing cancer vaccines, where he held the position as Research Director; it was dissolved in 2013. Dalgleish is a member of the medical board in Bionor Pharma. Dalgleish is on the scientific advisory board of Immodulon, and has stock options in Immunor AS, a disclosure he made in order to have his research work published. During the COVID-19 pandemic, Dalgleish was a proponent of the lab leak theory. While still not generally accepted, this remains a live debate, and it has been claimed that the support of Jay Bhattacharya and John Ratcliffe for the lab leak theory will bring "explosive documents" to light in 2025. ==2015 candidacy for Parliament==
2015 candidacy for Parliament
Dalgleish was a member of the UK Independence Party and stood as a candidate in Sutton & Cheam, during the 2015 United Kingdom general election finishing fourth with 10.7% of the vote. Dalgleish campaigned for Leave.EU and appeared on the BBC Radio 4 Today programme presenting the case for Brexit. He was an advocate of Leave Means Leave, a Eurosceptic group. ==Awards and honours==
Awards and honours
Dalgleish was elected a Fellow of the Academy of Medical Sciences in 2001 and is also a Fellow of the Royal College of Physicians the Royal College of Pathologists and a Fellow of the Royal Australasian College of Physicians. His citation on election to FMedSci reads: ==Covid controversies==
Covid controversies
In October 2023, following a joint investigation analysing emails leaked in 2022 by Russian hacking group working for the Russian FSB, an article was published by Computer Weekly and Byline Times containing several controversial claims about Angus Dalgleish. • That Dalgleish was a member of a secret group led by Richard Dearlove (former head of MI6), Gwythian Prins (a historian academic), and John Constable (of the Global Warming Policy Foundation) - who called themselves the "Covid Hunters". Also that Dalgleish had been given stock options in the company Immunor which held the patents for this vaccine due to his significant involvement in the research behind its development. • That when the scientific journal Nature Medicine published an article contradicting them on the origin of COVID-19, the group considered this to be COVID-19 misinformation by China. However this claim has been invalidated by multiple data sources that show Sweden was not exceptional in its covid death rates and had a similar outcome to many other EU countries including Ireland and Finland, both which had lockdowns and vaccines. " In a speech to the Reform Party Conference in September 2025 Aseem Malholtra, an adviser to US health secretary Robert F Kennedy Jr, said: "One of Britain's most eminent oncologists Professor Angus Dalgleish said to me to share with you today that he thinks it's highly likely that the Covid vaccines have been a significant factor in the cancers in the royal family." == Publications and contributions ==
Publications and contributions
According to Semantic Scholar, Dalgleish has 495 publications, 21,234 citations, and 541 "highly influential citations". • • ==Bibliography==
tickerdossier.comtickerdossier.substack.com